The Latest Breaking News from Ron Wyden

A senator and two congressmen team up to help protect whistleblowers from vindictive prosecution.

WASHINGTON — Democrats made concessions to get Sen. Joe Manchin III on board with spending hundreds of billions of dollars on clean energy incentives in the revamped budget package unveiled late Wednesday, but they were able to preserve versions of key pieces that he’d targeted as concerns.

Democrats made concessions to get Sen. Joe Manchin III on board with spending hundreds of billions of dollars on clean energy incentives.

California’s experience shows why burdensome taxes and regulations, as in Sen. Chuck Schumer’s proposed bill, would drive consumers away from the legal pot market.

WASHINGTON — As the House Energy and Commerce Committee approved a federal data privacy bill last week, lawmakers on the House Judiciary Committee were looking to plug a gap in the law that allows government agencies to conduct broad surveillance without obtaining warrants or subpoenas to do so.

The Senate majority leader’s marijuana bill would pile on more taxes and regulations, despite years of complaints about the barriers they create.

Lawmakers say government purchases of data from private companies violates the Fourth Amendment and are looking to close the gap.

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Tilray Brands, Inc (NASDAQ: TLRY) gapped up about 4.5% higher on Thursday on news that the Cannabis Administration And Opportunity Act (CAOA) has been introduced in the U.S. Senate.

A long-awaited U.S. Senate legislation that would decriminalize and deschedule cannabis on the federal level, while also promoting social equity, has finally been unveiled.